Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05907681

Enrollment

400

Registered

2023-06-18

Start date

2023-05-11

Completion date

2033-12-31

Last updated

2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication

Brief summary

This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

19 Years to 100 Years

Healthy volunteers

Inclusion criteria

* histologically confirmed breast cancer * presence of distant metastasis * radiation therapy using IMRT, SBRT, or proton therapy is done or planned * Able and willing to comply with the study protocol

Exclusion criteria

* unable to adhere to the study protocol

Design outcomes

Primary

Measure	Time frame	Description
Local control rate	1-year	LC after radiation therapy

Secondary

Measure	Time frame	Description
Overall survival rate	1-year	—
Disease-free survival	1-year	disease-free survival rate after the time of RT
Treatment-related toxicities	1-year	Acute and chronic radiation toxicities according to CTCAE v5.0

Countries

South Korea

Contacts

Primary ContactHaeyoung Kim

haeyoung0131.kim@samsung.com+82-02-3410-2612

Backup Contactwon kyung Cho

wklove.cho@gmail.com+821087328703

Outcome results